The FDA has started a priority review of MSD's Keytruda as neoadjuvant and adjuvant treatment of locally advanced head and neck squamous cell carcinoma (HNSCC), with a decision due by 23rd June.

Fit is handled with adjustable shoulder and side straps, and the protector is fully compatible with Leatt’s neck brace system. The side straps aren’t as refined as what you’ll find on ...

Sports News, Scores, Fantasy Games ...